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We report successful reconstruction of a challenging composite chest wall defect in
an immunocompromised patient using a biologic mesh. Infection results in signiﬁcant
morbidity and mortality in immunocompromised patients. Thus, reconstruction in this
population requires careful selection of appropriate materials to repair the defect. A 26-
year-old woman with a cardiac paraganglioma required resection of the heart, portions
of the great vessels, several ribs, and a large portion of the sternum, with subsequent
orthotopiccardiactransplantation.Titaniumplateswereusedtorestoresternalcontinuity
and Strattice was used for chest wall reconstruction. Strattice was selected due to its
ability to become incorporated and resist wound infection, to provide stability to the rib
cage, and to protect the newly transplanted heart. In our experience, Strattice provides a
viable alternative to other biologics and is a safer alternative to synthetic mesh for chest
wall reconstruction in immunocompromised patients.
Each year, 3500 orthotopic heart transplants are performed worldwide, of which a
small percentage are for primary cardiac tumors.1 Treatment of these tumors may require
extensiveresectionofthechestwall,inadditiontoahearttransplant,resultingincomposite
chest wall defects that require reconstruction.
Cardiac transplant patients are maintained on lifelong immunosuppression, which
can inﬂuence the method of chest wall reconstruction. Chest wall skeletal defects have
traditionally been repaired using Prolene or polytetraﬂouroethylene mesh, Gore-Tex soft-
tissue patch, or a methyl methacrylate sandwich.2 Unfortunately, these synthetic materials
are unable to resist infection, which is a devastating complication in heart transplant pa-
tients, accounting for 30% of the mortality in the ﬁrst year.1-3 The risk of infection in an
immunocompetent patient is 0.4% to 5.1% following median sternotomy; however, in im-
munosuppressedpatients,theriskismuchhigher.4-6 Thesepatientscanbeneﬁtsigniﬁcantly
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from chest wall reconstruction using a biologic mesh that promotes tissue incorporation
and resists infection.
We report the use of non–cross-linked acellular porcine dermal matrix (Strattice,
Lifecell Corporation, Branchburg, New Jersey) to reconstruct a large, composite chest wall
defect in an orthotopic heart transplant patient following resection of a primary cardiac
paraganglioma. The use of Strattice for chest wall reconstruction in an immunosuppressed
patient has not been reported previously.
CASE
A 26-year-old African American woman presented for an orthotopic heart transplantation
following staged resection for a cardiac paraganglioma. The oncologic treatment included
an en bloc resection of the heart, portions of the great vessels, several ribs and a portion
of pectoralis major muscle (Fig 1). The plastic surgery department evaluated the patient
intraoperatively for chest wall reconstruction. It was noted that the sternum was divided
in the midline and a large portion of the left sternal body, along with 4 ribs to the anterior
axillary line, had been resected en bloc with the specimen. This resulted in a 10 × 10 cm2
chest wall defect (Fig 2), and a decision was made to proceed with Strattice for chest wall
reconstruction. Multiple interrupted 0 polydioxanone suture (PDS) sutures were placed in
horizontal mattress fashion 270◦ around the defect through the ribs and intercostal muscu-
lature.The Stratticewas trimmed to ﬁt the chestwalldefectand was parachutedunderneath
the rib edges to minimize contact between the bony edges and the heart. The Strattice was
then serially secured in place, creating a tight construct to replace the missing segment of
chest wall (Fig 3). Bone reduction clamps were used to reduce and align the manubrium
and residual body of the sternum. Rigid ﬁxation was provided with a locking sternal
plating system. The medial edge of the Strattice was then aligned with the contralateral
sternum/ribs and this was secured with interrupted ﬁgure of eight 0 PDS sutures.
Muscle coverage for the implants was obtained by elevating the residual pectoralis
muscle on the left and approximating this to a composite pectoralis myocutaneous ﬂap that
was elevated from the right chest. The patient did well postoperatively and was discharged
homeonpostoperativeday16.A9-monthcomputedtomographicscanshowsstableinternal
reconstruction and no ﬂuid collection around the graft (Fig 4). At a 14-month postoperative
visit, her chest wall construct was stable and healing without evidence of infection. A
14-month follow-up image shows the scar is well healed and without signs of infection or
dehiscence (Fig 5).
DISCUSSION
Infection results in signiﬁcant morbidity and mortality in immunocompromised patients.
Reconstruction in this population requires selection of appropriate materials to repair the
defect. Synthetic mesh is susceptible to infection and vascularized tissue ﬂaps may provide
coverage but lack structural support for larger defects. Therefore, chest wall reconstruction
with biologic materials is a safer alternative that will resist infection and provide structural
support.7
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Figure 1. The intraoperative specimen of heart, great vessels, and adjacent structures.
AlloDerm (Lifecell Corporation, Branchburg, New Jersey) human acellular dermal
matrix is a biologic mesh that has been studied extensively in humans and animals. The
AlloDerm tissue matrix is integrated into the body through rapid revascularization, white
cell migration, and cell repopulation, which allows it to resist infection and allows for local
treatment of infection.7 Cothren et al8 reported a case in which AlloDerm was used in
combination with a latissimus dorsi muscle ﬂap to reconstruct a 20 × 20 cm2 chest wall
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defect after resection of a spindle cell sarcoma. They found it to be an ideal material,
providing adequate structural stability with a reduction in the incidence of infection. One
of its drawbacks for chest wall reconstruction, however, is its tendency to stretch over
time.9
Figure 2. A1 0× 10 cm2 chest wall defect after en bloc resection of specimen.
Strattice is a biologic mesh made from porcine dermal matrix that incorporates much
like AlloDerm. Strattice has been shown in primate models to become revascularized in
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the abdominal wall without immunologic rejection.10 The use of Strattice has also been
reported as reinforcement for component separation in ventral hernia repair where it has
also been found to adequately resist infection.11
Figure 3. Intraoperative photos showing the biologic mesh secured in place to replace the
missing segment of chest wall.
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Figure 4. Computed tomographic image shows stable inter-
nal reconstruction at 9 months with no ﬂuid collection around
the graft.
Figure 5. At 14-month follow-up, the scar is well healed with no
signs of infection or dehiscence. A prior keloid on breast and mild
keloid from sternotomy incision are present.
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Despite the ability of both AlloDerm and Strattice to become revascularized and resist
infection, there are some important differences that make Strattice a preferred biologic
mesh for this indication. Strattice is less elastic and can be harvested in larger and more
consistent sheets, allowing for repair of larger defects with a single piece. In addition,
the supply of porcine skin is greater than that of human cadaveric skin and can be easily
obtainedatasubstantiallyreducedcost.12,13 Perhapsitsgreatestfeatureisitsabilitytoresist
stretching, while still being incorporated like its allogenic counterparts.12 In short, these
qualities make Strattice an ideal biologic mesh for the repair of large chest wall defects in
immunosuppressed patients.
In this case, we used titanium plates to rigidly ﬁxate the remaining sternum and
manubrium. Rigid ﬁxation is associated with improved bone healing and decreased bone
infection.4 If, however, there was an early wound infection, the titanium plates could be
removed while leaving the Strattice in place, protecting the heart. In the later phases of con-
valescence, the hardware could also be removed (after bony union) while still maintaining
durable cardiac coverage with Strattice.
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